Skip to content

Clinical trials

Mental Disorders trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Hungary Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20121
20131
20143
20171
20191
20201
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
AbbVie2
AstraZeneca2
Emalex Biosciences Inc.1
H. Lundbeck A/S1
Hospital Vall d'Hebron1
MapLight Therapeutics1
Pierre Fabre Medicament1
Semmelweis University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders16
Brain Diseases6
Central Nervous System Diseases6
Depressive Disorder4
Major Depressive Disorder4
Nervous System Diseases4
Alzheimer Disease3
Dementia3
Mood Disorders3
Movement Disorders3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.